Moderna hits Pfizer and BioNTech with COVID-19 vaccine patent suit
Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
GSK presses court to deny Teva’s ‘skinny label’ petition
Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
US med-tech secures victory in drug transfer system dispute
Illinois court rules company’s syringe to drug vial system doesn’t infringe | System’s components can be used for other purposes.
Wilson Sonsini hire boosts IP and life sciences prowess
Firm appoints new partner with ‘extensive’ in-house and experience | Move follows key office move to Colorado where life sciences sector ‘flourishing’.
Gilead must face pay-for-delay suit
Class-action alleges pharma company blocked rival HIV drug | Health insurance trust convinces judge a reverse payment may have been made.
Jones Day hires new counsel for New York IP practice
Jones Day has announced that Yi Han Dulkeith has joined the firm’s IP practice in New York.
French healthcare company makes $1.2bn AI drug discovery deal
Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.
Bausch Health unit prevails in patent dispute
New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents.
Japanese pharma company wins arbitration over cancer drug
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.
Fed Circuit rejects Minerva patent invalidation bid
Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.
